BRITTANIE MCCOY: Open Payments
NPI 1760044275 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 67 payments from 21 companies in 2025. Trend: 2023 $1,767 · 2024 $968 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $161 |
| AstraZeneca Pharmaceuticals LP | 4 | $145 |
| ABBVIE INC. | 6 | $108 |
| SANOFI-AVENTIS U.S. LLC | 4 | $82 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| Novo Nordisk Inc | 5 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| Amgen Inc. | 4 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
Products named: Kerendia, XIFAXAN, TZIELD, TRELEGY ELLIPTA, UBRELVY, CAPLYTA, OTEZLA, GEMTESA.
Industry payments across KY — which companies pay providers there.
